Warning: Testosterone Replacement Clinics

    The number of Testosterone replacement clinics that are sprouting up is impressive. Looking at the credentials of the physicians are impressive. The one unimpressive factor is that the majority of them are breen with only a few years of experience.  The Millennium has over 15 years experience in treating not only Testosterone Deficiencies but excess.

When you make that decision to venture forward to be evaluated for Testosterone Deficiency know that you have not only experience but, a flexibility in treatment programs that comes only from years of experience. Most new physicians are limited in using a topical preparation while we offer 4 different delivery modalities to match your life style and preferences. Not everyone responds best to topical products. When we use injectable Testosterone, we never have needed additional medications to counter the side-effects. Why? We know how to do it right!  When you are ready, call the office and I will set aside time to talk with you over the phone. Looking forward to that time..

Low Testosterone Syndrome 

It is now generally agreed that male aging is associated with a slow and progressive decrease in serum T concentrations. The decreases in serum T may be accompanied by a constellation of symptoms including sexual dysfunction, lack of energy, loss of muscle and bone mass, increased frailty, loss of balance,cognitive impairment, and decreased general well being;a condition termed "andropause"; or androgen deficiency of aging. Some of these clinical symptoms are relieved by replacement therapy with intramuscular T injections or transdermal T applications.

Short-term studies have reported that T replacement resulted in variable improvement in sexual function, muscle and bone mass, and quality of life in older men . In a placebo-controlled randomized clinical trial, a transdermal T patch administered for 3 yr decreased body fat and increased lean body mass but failed to demonstrate significant changes in muscle strength or bone mass. This study has been criticized by some for its design limitations, including its inclusion of men with T levels within the normal range for young healthy men. Nevertheless,the authors provided further analyses demonstrating that bone mass was increased in men with the lower serum T levels and lower pretreatment bone mineral density.

In these studies, serum prostate-specific antigen (PSA) concentrations and clinical evidence of prostate disease were not different between the placebo- and T-treated groups. In aging men, the benefits of androgen replacement must be weighed against the potential risks.

The important question of whether chronic T replacement in aging men with partial androgen deficiency will induce prostate cancer or promote conversion of histological to clinically evident prostate cancer remains unanswered. The clinical trials conducted, to date, have insufficient power to address this question. by Dr. Ronald Swerdloff